178 related articles for article (PubMed ID: 12815067)
1. Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein.
Taylor JP; Taye AA; Campbell C; Kazemi-Esfarjani P; Fischbeck KH; Min KT
Genes Dev; 2003 Jun; 17(12):1463-8. PubMed ID: 12815067
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
[TBL] [Abstract][Full Text] [Related]
3. Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene.
Petruk S; Sedkov Y; Smith S; Tillib S; Kraevski V; Nakamura T; Canaani E; Croce CM; Mazo A
Science; 2001 Nov; 294(5545):1331-4. PubMed ID: 11701926
[TBL] [Abstract][Full Text] [Related]
4. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
[TBL] [Abstract][Full Text] [Related]
5. CREB-binding protein sequestration by expanded polyglutamine.
McCampbell A; Taylor JP; Taye AA; Robitschek J; Li M; Walcott J; Merry D; Chai Y; Paulson H; Sobue G; Fischbeck KH
Hum Mol Genet; 2000 Sep; 9(14):2197-202. PubMed ID: 10958659
[TBL] [Abstract][Full Text] [Related]
6. Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation.
Singh MD; Raj K; Sarkar S
Neurobiol Dis; 2014 Mar; 63():48-61. PubMed ID: 24291519
[TBL] [Abstract][Full Text] [Related]
7. The SV40 T antigen modulates CBP histone acetyltransferase activity.
Valls E; de la Cruz X; Martínez-Balbás MA
Nucleic Acids Res; 2003 Jun; 31(12):3114-22. PubMed ID: 12799439
[TBL] [Abstract][Full Text] [Related]
8. Polyglutamine disease: acetyltransferases awry.
Hughes RE
Curr Biol; 2002 Feb; 12(4):R141-3. PubMed ID: 11864588
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.
Palhan VB; Chen S; Peng GH; Tjernberg A; Gamper AM; Fan Y; Chait BT; La Spada AR; Roeder RG
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8472-7. PubMed ID: 15932940
[TBL] [Abstract][Full Text] [Related]
10. The acetyltransferase activity of CBP is required for wingless activation and H4 acetylation in Drosophila melanogaster.
Ludlam WH; Taylor MH; Tanner KG; Denu JM; Goodman RH; Smolik SM
Mol Cell Biol; 2002 Jun; 22(11):3832-41. PubMed ID: 11997517
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between the coactivator Drosophila CREB-binding protein and ASH1, a member of the trithorax group of chromatin modifiers.
Bantignies F; Goodman RH; Smolik SM
Mol Cell Biol; 2000 Dec; 20(24):9317-30. PubMed ID: 11094082
[TBL] [Abstract][Full Text] [Related]
12. The PHD type zinc finger is an integral part of the CBP acetyltransferase domain.
Kalkhoven E; Teunissen H; Houweling A; Verrijzer CP; Zantema A
Mol Cell Biol; 2002 Apr; 22(7):1961-70. PubMed ID: 11884585
[TBL] [Abstract][Full Text] [Related]
13. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
[TBL] [Abstract][Full Text] [Related]
14. Tat-controlled protein acetylation.
Col E; Gilquin B; Caron C; Khochbin S
J Biol Chem; 2002 Oct; 277(40):37955-60. PubMed ID: 12154097
[TBL] [Abstract][Full Text] [Related]
15. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
[TBL] [Abstract][Full Text] [Related]
16. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
Nucifora FC; Sasaki M; Peters MF; Huang H; Cooper JK; Yamada M; Takahashi H; Tsuji S; Troncoso J; Dawson VL; Dawson TM; Ross CA
Science; 2001 Mar; 291(5512):2423-8. PubMed ID: 11264541
[TBL] [Abstract][Full Text] [Related]
17. CBP, a transcriptional coactivator and acetyltransferase.
McManus KJ; Hendzel MJ
Biochem Cell Biol; 2001; 79(3):253-66. PubMed ID: 11467739
[TBL] [Abstract][Full Text] [Related]
18. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors reduce polyglutamine toxicity.
McCampbell A; Taye AA; Whitty L; Penney E; Steffan JS; Fischbeck KH
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15179-84. PubMed ID: 11742087
[TBL] [Abstract][Full Text] [Related]
20. Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation.
Igarashi S; Morita H; Bennett KM; Tanaka Y; Engelender S; Peters MF; Cooper JK; Wood JD; Sawa A; Ross CA
Neuroreport; 2003 Mar; 14(4):565-8. PubMed ID: 12657886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
